TDOC Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
606.9M
-1.1%
613.8M
-4.4%
642.3M
+2.5%
626.4M
-0.9%
631.9M
Cost of Revenue
190.8M
-3.4%
197.5M
+0.2%
197.0M
+5.3%
187.2M
-1.8%
190.5M
Gross Profit
416.1M
-0.1%
416.3M
-6.5%
445.2M
+1.4%
439.3M
-0.5%
441.4M
Operating Expenses
451.5M
-5.6%
478.1M
-0.7%
481.2M
-2.0%
491.2M
-0.4%
493.1M
R&D
62.9M
-7.4%
67.9M
-5.2%
71.6M
+6.0%
67.6M
-1.8%
68.8M
SG&A
296.8M
-2.6%
304.9M
-0.3%
305.7M
-4.1%
318.8M
-2.1%
325.6M
Operating Income
-35402000
+42.7%
-61768000
-71.6%
-35997000
+30.7%
-51962000
-0.5%
-51727000
EBITDA
56.4M
+29.5%
43.6M
-35.8%
67.9M
+28.3%
52.9M
+12.7%
47.0M
Net Income
-38908000
+39.1%
-63837000
-153.9%
-25143000
+49.2%
-49507000
-51.6%
-32660000
EPS (Basic)
$-0.21
+41.7%
$-0.36
-157.1%
$-0.14
+50.0%
$-0.28
-47.4%
$-0.19
EPS (Diluted)
$-0.21
+41.7%
$-0.36
-157.1%
$-0.14
+50.0%
$-0.28
-47.4%
$-0.19
Shares (Diluted)
181.0M
+1.1%
179.1M
+0.7%
177.9M
+0.5%
176.9M
+0.6%
175.9M
Teladoc Health (TDOC) โ€” Financials